Want to join the conversation?
$LLY said worldwide revenue grew 8% in 2Q16 driven entirely by volume. US pharma revenue increased 15% driven primarily by volume. In Japan, pharma revenue grew 21% driven by mid-teens volume growth and an 11% benefit from a stronger yen. In emerging markets, revenue declined 3% driven by negative effects of FX.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.